New Discovered Cannabinoid is the Fountain of Youth скачать в хорошем качестве

New Discovered Cannabinoid is the Fountain of Youth

JOIN OUR DISCORD WHERE YOU WILL GET EXCLUSIVE ACCESS TO A CONSULTANT DURING ALL BUSINESS HOURS: https://launchpass.com/next-gen-chemi... Questions? Help us help you more. Fill out this form. : https://docs.google.com/forms/d/e/1FA... DISCLAIMER: ALL VIDEOS ARE FOR EDUCATIONAL/ENTERTAINMENT PURPOSES ONLY. OPINIONS SHARED ON THIS CHANNEL ARE OPINIONS ONLY. ALL INFORMATION, PRACTICES, SUGGESTIONS, TIPS AND TRICKS ARE USED AT YOUR OWN RISK! Chemistry CAN BE dangerous. Please CONSULT or BECOME a professional before considering trying anything mentioned in these videos. Contact us @ 👇👇 ✍ Email: [email protected] Website: https://cannalabsconsulting.com/ LinkedIn:   / wkuconsulting   Facebook:   / wkuconsulting   Turnkey Cannabis Ecosystem: https://seed2shelf.us/ Instagram:   / wkuconsulting   0:00 – Intro Host welcomes cannabis enthusiasts, mentions popular cannabinoids (THC, CBD, CBN, THCP), and teases a new discovery that’s shaking up cannabinoid science. 0:30 – Meet CBGD Introduces CBGD (Cannabizetol), a rare new cannabinoid. Clarifies the name confusion with a neurological disorder and outlines the goal: what it is, why it’s rare, and why it matters. 1:00 – Discovery & Origins Discovered by Italian and Swiss researchers in Cannabis sativa. Linked to the same team that identified THCP, THCH, THCB, and THCM. Published in Journal of Natural Products (Sept 2025). 2:20 – Unique Structure CBGD is a dimeric cannabinoid — two cannabinoid molecules joined by a single-carbon (CH₂) bridge. Only the third of its kind ever found, alongside Cannabizetol (THC dimer) and Cannabitwinol (CBD dimer). 3:10 – Formation Mechanism Unlike enzyme-driven cannabinoids, CBGD forms accidentally through non-enzymatic dimerization. Likely involves formaldehyde or even mold-derived carbon units. Appears only in trace amounts — a true rarity. 4:10 – Biological Activity Early studies reveal strong antioxidant and anti-inflammatory effects, surpassing CBD. Acts by inhibiting the NF-κB pathway, reducing inflammation in skin cells — promising for eczema, psoriasis, and redness. 6:00 – Research-Only Synthesis (Simplified Overview) Mentions a theoretical lab process: reacting CBD with formaldehyde in ethanol under reflux (~78 °C, 48 h). Very low yield (~19%). Discussed for educational purposes — purification needed via chromatography. 8:30 – Inflammaging & Medical Potential Links chronic low-grade inflammation (“inflammaging”) to age-related disease. CBGD could counteract it, offering new avenues in anti-aging, dermatology, and therapeutic cannabinoid science. 10:00 – Conclusions Summarizes: CBGD is a novel methylene-bridged dimeric cannabinoid with unique structure and powerful skin benefits. Calls for further research and pharmaceutical attention. 11:00 – Closing & Channel Anniversary Celebrates 4 years of WKU Consulting. Thanks viewers, highlights the excitement of ongoing cannabinoid discovery, and invites them to watch related videos. ✅ Summary Takeaway: CBGD (Cannabizetol) is a newly discovered methylene-bridged dimeric cannabinoid, distinct from others like CBD or THC. Though extremely rare and found in trace quantities, early studies show it possesses remarkable anti-inflammatory and antioxidant properties, especially for skin health. Its discovery may signal a new era in medicinal and cosmetic cannabinoid research.